What do 1,000+ trials say — and where does the evidence still honestly thin?
Creatine's evidence base is the largest in this library: the performance effect is among the most replicated findings in nutrition science (more high-intensity work capacity, confirmed across hundreds of trials), the aging-muscle literature is strong and growing, the cognitive evidence is the promising frontier (population-conditional: vegetarians, sleep-deprived, aging), and the safety record spans decades. The honest boundaries: endurance performance shows little, the female data are historically thin (and catching up), and the premium-form claims outrun their outcome data.
The field's size teaches its own reading skills:
The French chemist extracts the compound from meat and names it from the Greek 'kreas' — flesh. The molecule is known before its function.
The phosphorylated storage form is identified in muscle — the energy-buffer system begins to take shape.
The enzyme that regenerates ATP from phosphocreatine is characterized — bioenergetics research recognized with Nobel work.
Christie and Gunnell win gold; the creatine story goes public; the supplement industry's most-studied product launches.
The International Society of Sports Nutrition's formal position: the most effective legal ergogenic aid for high-intensity capacity — updated repeatedly as the evidence grew.
The vegetarian trials, the sleep-deprivation studies, the sarcopenia literature — the buffer's story expands from muscle to brain to geriatrics.
The historical male-data gap closes: women's responses confirmed, the nuances mapped, the 30-year assumption finally tested.
POPULATION · 45 vegetarian young adults, 5 g creatine daily vs. placebo, 6 weeks, cognitive battery
FINDING · Significant improvements in memory and intelligence measures in the creatine group — the vegetarian baseline producing the largest cognitive response.
LIMITATION · Young adults (a cognitive peak population); the omnivore comparison groups in the broader literature show much smaller effects — the population-conditional claim this page grades as moderate, not universal.
POPULATION · Women across the recent catch-up creatine literature (performance, cognition, baseline-store mapping)
FINDING · Women respond to creatine supplementation in both muscle and cognitive measures — with baseline stores and hormonal-phase nuances shaping magnitude, and no safety divergence from the male record.
LIMITATION · The literature is young and the sample sizes modest — the correction is underway, not complete. The honest page states the gap and its closing.
POPULATION · Healthy adults across multi-year creatine-use studies (including 5 g+ daily for years)
FINDING · No kidney or liver harm demonstrated across decades of observation and controlled trials in healthy populations — the supplement world's longest clean safety record.
LIMITATION · The kidney-disease population is separately managed (physician-gated, as this page states throughout); and the creatinine-blood-test elevation (a known benign artifact of supplementation, not dysfunction) still causes clinical confusion — the myth's mechanism, documented and retired.